Italy: shareholders' equity to assets ratio of SMEs 2012-2016

Published by Statista Research Department, Dec 19, 2022
This statistic depicts the ratio between shareholders' equity and assets of small and medium-sized enterprises (SMEs) in Italy in 2012 and 2016. According to data, the shareholders' equity to assets ratio of SMEs was equal to 30.2 percent as of 2016, an increase of five percent compared to 2012.

Shareholders' equity to assets ratio* of small and medium-sized enterprises (SMEs) in Italy in 2012 and 2016

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2018

Region

Italy

Survey time period

2012 and 2016

Supplementary notes

* The shareholders' equity to assets ratio indicates how much of a company's assets are funded by shareholder equity. It is an indicator of a companies financial soundness: the closer it is to 100%, the more assets are financed with equity instead of taking on debt.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Startups in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Startups in Italy

Overview in Europe

5

National landscape

7

Sectors and key players

5

Business environment

3

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Small and medium-sized biotech companiesGlobal pharmaceutical industryBiotech drugsTop pharmaceutical drugsBiotechnology in Europe
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu